“A型猪流感病毒H1N1-M2蛋白抗体,Anti-H1N1 Matrix Protein 2/Influenza A bp1抗体”我公司拥有领先的细胞服务技术,先进的仪器设备和专业的ELISA检测试剂盒、生物索标记、荧光索标记、酶标记等,广泛用于多种分析研究与技术测定。欢迎来电咨询,我们将竭诚为你服务!
博研生物抗体售前、售中、售后免费技术服务,欢迎致电索说明书
客服电话:021 60340850 021 60340830 021 60340820
客服QQ :827774711 349199432 372584443
产品名称 A型猪流感病毒H1N1-M2蛋白抗体,Anti-H1N1 Matrix Protein 2/Influenza A bp1抗体
产品编号 BYk-0422R
相关标记 HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-Cy5 PE-Cy5.5
PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647
浓 度 1mg/1ml
抗体来源 Rabbit OR MOUSE
克隆类型 polyclonal or monoclonal
产品类型 一抗
产品用途 科研实验,用于免疫组化实验,WB实验、IF、IP、ELISA实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
性 状 Lyophilized or Liquid
亚 型 IgG
A型猪流感病毒H1N1-M2蛋白抗体,Anti-H1N1 Matrix Protein 2/Influenza A bp1抗体保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
A型猪流感病毒H1N1-M2蛋白抗体,Anti-H1N1 Matrix Protein 2/Influenza A bp1抗体产品说明:
Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.